Innovation in biology is accelerating at a rate that makes Moore’s Law look leisurely, throwing open doors to opportunities unimaginable. From food to fuel, manufacturing to medicine, business to buildings, what do the visionaries see just beyond the horizon?
Stanford’s Drew Endy, Brian Frezza of Emerald Therapeutics, Nancy J. Kelley of the New York Genome Center, and Floyd Romesberg of The Scripps Research Institute discuss the social and economic impact of biotech in this discussion, moderated by Marcus Wohlsen of WIRED, from the opening day of the Techonomy 2014 conference in Half Moon Bay, Calif.
For a complete archive of videos from Techonomy 2014, click here.
Business + Innovation
The Next Revolution Will Be Biologized
Innovation in biology is accelerating at a rate that makes Moore’s Law look leisurely, throwing open doors to opportunities unimaginable. From food to fuel, manufacturing to medicine, business to buildings, what do the visionaries see just beyond the horizon? Stanford's Drew Endy, Brian Frezza of Emerald Therapeutics, Nancy J. Kelley of the New York Genome Center, and Floyd Romesberg of The Scripps Research Institute discuss the social and economic impact of biotech in this discussion, moderated by Marcus Wohlsen of WIRED, from the opening day of the Techonomy 2014 conference in Half Moon Bay, Calif.
